Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 541775 of 542236 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 03/31/09
Due: 03/31/10
Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 12/15/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/03/18
End: 07/30/21
Due: 07/30/22
Phase: N/A
Priority: Normal
Start: 08/31/23
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 10/01/21
Due: 10/01/22
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 04/15/17
End: 03/31/18
Due: 03/31/19
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 05/01/19
Due: 05/01/20
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 01/07/10
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 07/30/24
Due: 07/30/25
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 03/18/17
End: 03/28/18
Due: 03/28/19
Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 03/18/21
End: 06/24/24
Due: 06/24/25
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 01/31/10
Due: 01/31/11